ESRRA and ovarian carcinoma: Estrogen-related receptor α (ERRα) subtypes are highly expressed in malignant tumors, especially in hormone-dependent/related tumors, such as breast cancer (BRCA) (21), prostate cancer (PCa) (22), ovarian cancer (23), and endometrial cancer (24–26).